ArticleOncoimmunology2020

Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma.

Alexandra Drakaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.